Douglas K. Price
- Cancer Research top 2%
- Cancer, Lipids, and Metabolism 14
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 10
- Oncology top 2%
- Drug Transport and Resistance Mechanisms 10
-
- Prostate Cancer Treatment and Research 59
- Prostate Cancer Diagnosis and Treatment 13
- Molecular Biology top 5%
- Sexual Differentiation and Disorders 11
-
- Hormonal and reproductive studies 18
-
- Estrogen and related hormone effects 11
- Co-authors
- William D. FiggTristan M. SissungCindy H. ChauAlex SparreboomWilliam L. DahutRomano DanesiDavid VenzonSeth M. Steinberg
- Cited by
- Cancer ResearchPharmacologyOncology
- Journals
- Journal of Clinical Investigation (1 paper)Journal of Clinical Oncology (11 papers)PLoS ONE (2 papers)
- Partner nations
- United StatesItalyAustralia
In The Last Decade
Douglas K. Price
111 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 127
- Cancer Research 698
- Pharmacology 362
- Oncology 1.1k
- Pulmonary and Respiratory Medicine 1.0k
- Molecular Biology 1.6k
Countries citing papers authored by Douglas K. Price
This map shows the geographic impact of Douglas K. Price's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas K. Price with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas K. Price more than expected).
Fields of papers citing papers by Douglas K. Price
This network shows the impact of papers produced by Douglas K. Price. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas K. Price. The network helps show where Douglas K. Price may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Douglas K. Price, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 2 | |
| 3 | 2021 | 18 | |
| 4 | 2021 | 12 | |
| 5 | 2020 | 71 | |
| 6 | 2020 | 7 | |
| 7 | 2010 | 24 | |
| 8 | 2010 | 31 | |
| 9 | 2010 | 5 | |
| 10 | 2009 | 146 | |
| 11 | 2008 | 153 | |
| 12 | ABCB1 genetic variation influences the toxicity and clinical outcome of patients treated with docetaxel | 2008 | 1 |
| 13 | 2008 | 43 | |
| 14 | 2007 | 16 | |
| 15 | 2005 | 137 | |
| 16 | 2004 | 86 | |
| 17 | 2004 | 10 | |
| 18 | 2003 | 22 | |
| 19 | 2000 | 4 | |
| 20 | 1995 | 7 |
About Douglas K. Price
Douglas K. Price is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology, having authored 114 papers that have together received 3.3k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (59 papers), Hormonal and reproductive studies (18 papers), Cancer, Lipids, and Metabolism (14 papers), Prostate Cancer Diagnosis and Treatment (13 papers), Sexual Differentiation and Disorders (11 papers), Estrogen and related hormone effects (11 papers), Pharmacogenetics and Drug Metabolism (10 papers) and Drug Transport and Resistance Mechanisms (10 papers). The work is most often cited by research in Cancer Research (698 citations), Pharmacology (362 citations) and Oncology (1.1k citations). Douglas K. Price has collaborated with scholars based in United States, Italy and Australia. Frequent co-authors include William D. Figg, William D. Figg, Tristan M. Sissung, Cindy H. Chau, Alex Sparreboom, William L. Dahut, Romano Danesi, David Venzon, Seth M. Steinberg and Caitlin E. Baum. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.